GLP-1 Is Changing How People Eat.
Is Your Brand Ready?
The rise of GLP-1 medications like Ozempic and Mounjaro is reshaping consumer behaviour at unprecedented speed. Cravings are fading. Portions are shrinking. Indulgence is being replaced by function. Appetite itself is being redefined. At F!S Group, we’re tracking this seismic shift—and helping food and drink brands decode what it means.
This isn’t a future trend. This is already happening.
Across strategic PEST analyses, food businesses are starting to name it: Appetite suppression is
an emerging threat—and opportunity. The socio-cultural and technological forces behind GLP-1
adoption are accelerating. Your products, claims and formats must evolve, fast.